APA (7th ed.) Citation

King, B., Zhang, X., Harcha, W. G., Szepietowski, J. C., Shapiro, J., Lynde, C., . . . Wolk, R. (2023). Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: A randomised, double-blind, multicentre, phase 2b–3 trial. Lancet, 401(10387), 1518. https://doi.org/10.1016/S0140-6736(23)00222-2

Chicago Style (17th ed.) Citation

King, Brett, et al. "Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: A Randomised, Double-blind, Multicentre, Phase 2b–3 Trial." Lancet 401, no. 10387 (2023): 1518. https://doi.org/10.1016/S0140-6736(23)00222-2.

MLA (9th ed.) Citation

King, Brett, et al. "Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: A Randomised, Double-blind, Multicentre, Phase 2b–3 Trial." Lancet, vol. 401, no. 10387, 2023, p. 1518, https://doi.org/10.1016/S0140-6736(23)00222-2.